Search

Search Results

• New anticancer medicines approved by the EMA in 2025

  Miklós Bege

  Anikó Borbás

  Views:

  17

  Despite the serious progress in the antitumor therapy, cancer did not cease to be one of the leading causes of death in the developed world. Hence still there is high interest for new anticancer agents. In 2025, the EMA approved 104 new medicines, 37 of them containing new active substances. 18 new anticancer medicines were approved (14 new active substances).  In this review, we aim to shortly summarize the mechanism of action and use of the new drugs approved by the EMA in the year 2025.

• New anticancer medicines approved by the EMA in 2024

  Miklós Bege

  Anikó Borbás

  Views:

  239

  Tumorous diseases are among the leading causes of death in the developed world, therefore there is a constant need for new antineoplastic medicines. In 2024, the EMA approved 28 anticancer drugs, of which 13 contains new active substances. In this review, we briefly summarize the mechanism of action and use of the new drugs approved by the EMA.